Ginger: Panacea or Consumer’s Hype?
AbstractGinger in its many forms, from juices of the fresh rhizome, to ginger powder and ginger essential oil, is growing in popularity for claimed universal health benefits. Nevertheless, and contrarily to the common notion of the public, ginger is not devoid of side effects, especially interactions with other drugs, and many of the claimed benefits remain to be substantiated. This work presents a comprehensive revision of the current state of the art on ginger pharmacokinetics and bioavailability, interaction with active pharmaceutical ingredients, raising awareness of the risks of uncontrolled ginger consumption. A second section of the work described the verified actions of various extracts of ginger, or of their main active ingredients, gingerols, based mainly on data obtained from controlled clinical trials. Finally, the last section is devoted to innovative technological solutions to improve the bioavailability of gingerols and ginger extracts that are expected to ultimately lead to the development of more consumer-compliant products. View Full-Text
Share & Cite This Article
Santos Braga, S. Ginger: Panacea or Consumer’s Hype? Appl. Sci. 2019, 9, 1570.
Santos Braga S. Ginger: Panacea or Consumer’s Hype? Applied Sciences. 2019; 9(8):1570.Chicago/Turabian Style
Santos Braga, Susana. 2019. "Ginger: Panacea or Consumer’s Hype?" Appl. Sci. 9, no. 8: 1570.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.